Nitroglycerin, also known as glyceryl trinitrate, is an organic nitrate and a vasodilating agent that was first discovered in 1847. Originally used to dynamite, its antianginal effects were identified in the late 1860s after it produced headaches in factory workers while workers with angina pectoris or heart failure experienced relief from chest pain. Its u...
Sublingual nitroglycerin is indicated for the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease. Transdermal nitroglycerin is indicated for the prevention of angina pectoris due to coronary artery disease.
...
Centinela Hospital Medical Center, Inglewood, California, United States
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
Zhongshan Hospital Fudan University, Shanghai, Shanghai, China
Department of Anesthesiology, Faculty of Medicine, Siriraj Hospital, Bangkok, Thailand
University of Iowa-Institute for Clinical and Translational Science, Iowa City, Iowa, United States
Kyoto University Hospital, Kyoto, Japan
Mayo Clinic, Rochester, Minnesota, United States
Johns Hopkins University, Baltimore, Maryland, United States
Boston University, Boston, Massachusetts, United States
University of Minnesota, Minneapolis, Minnesota, United States
Danish Headache Center, University of Copenhagen, Faculty of Health Sciences, Department of Neurology, Glostrup Hospital, Glostrup, Copenhagen, Denmark
University Hospital Ghent, Ghent, Belgium
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.